A Clinical Trial for the use of Intralesional Radiofrequency Ablation in the treatment Of Vascular Malformations

An Observational-Phase Clinical Trial for Intralesional Radiofrequency Ablation in the treatment of Vascular Malformations - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057170

Enrollment

Registered

2023-09-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q279- Congenital malformation of peripheral vascular system, unspecified

Interventions

Intervention1: Intralesional Radiofrequency Ablation at 4th and 5th month ( 2 sessions): The vascular malformation will be first observed which will be taken as control, followed by intervention by in

Eligibility

Inclusion criteria

Inclusion criteria: Patients of 5 years and above with low flow vascular malformations

Exclusion criteria

Exclusion criteria: 1. High flow(arterial) vascular malformation 2. Flat capillary vascular malformation 3. Uncontrolled diabetes mellitus 4. Uncontrolled hypertension 5. Low platelet count 6. History of bleeding disorders 7. History of use of anticoagulants, artificial implants and pacemakers, 8. Pregnant and lactating women 9. Allergy to local anaesthetic.

Design outcomes

Primary

Measure	Time frame
Reduction in volume of vascular malformations both clinically and by ultrasound Adverse effects of treatment.Timepoint: 0,16,20,24,28,32weeks	—

Secondary

Measure	Time frame
Reduction in VAS (Visual analogue scale- patient) score Reduction in symptoms Reduction in DLQI (Dermatology life quality index)Timepoint: 0,16,20,24,28,32 weeks	—

Countries

India

Contacts

Public ContactAyush Jain

All India Institute of Medical Sciences, Delhi

someshgupta@aiims.edu011-26593217

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026